G12D (p.Gly12Asp) variant of KRAS (GTPase KRas)
G12D (p.Gly12Asp) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Congenital Pulmonary Airway Malformations; KRAS-related disorder; Lung cancer. The available variant effect predictions contribute to a CATVariant prioritization score of 0.79 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.
G12D (p.Gly12Asp) variant details
- p.Gly12Asp
- rs121913529
- ClinGen CA122538
- NCI-TCGA Cosmic COSV5549
- cosmic curated COSV55497
- Pathogenic/Likely pathogenic
- Congenital Pulmonary Airway Malformations; KRAS-related disorder; Lung cancer
- Missense
- Variant Prioritization Score for Impact Estimate 0.793
- REVEL 0.88
- ESM-1b 1.00
- AlphaMissense 1.00
- MetaLR 0.58
- MetaSVM 0.27
- CADD 27.50
- ClinVar: Pathogenic/Likely pathogenic (Congenital Pulmonary Airway Malformations; KRAS-related disorder)
- EBI: Pathogenic (in GASC, JMML, SFM and RALD2)
- UniProt: Pathogenic (in GASC, JMML, SFM and RALD2)
- Most common in the Non-Finnish European population (allele frequency 2.9e-05)
- Structural context available
- KRAS activity — DMSO (standardized): score 10.1
- Cited in: Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with… (PMID 16533793)
- Cited in: The consensus coding sequences of human breast and colorectal cancers. (PMID 16959974)